2-hydroxylaminopropane: RN given refers to parent cpd
ID Source | ID |
---|---|
PubMed CID | 78763 |
CHEMBL ID | 140282 |
MeSH ID | M0105000 |
Synonym |
---|
3nt440v34t , |
2-propanamine, n-hydroxy- |
unii-3nt440v34t |
5080-22-8 |
einecs 225-791-1 |
n-hydroxyisopropylamine |
ec 225-791-1 |
n-isopropylhydroxylamine |
2-hydroxylaminopropane |
CHEMBL140282 |
n-isopropyl-hydroxylamine |
n-hydroxypropan-2-amine |
n-propan-2-ylhydroxylamine |
AKOS006230300 |
n-(propan-2-yl)hydroxylamine |
isopropylhydroxylamine |
n-isopropylhydroxylamine # |
DTXSID6063694 , |
hydroxylamine, n-isopropyl- |
n-hydroxy-2-propanamine |
isopropyl hydroxyamine |
mfcd02874394 |
FT-0719142 |
n-isopropylhydroxylamine;n-hydroxypropan-2-amine;2-propanamine, n-hydroxy-;2-hydroxylaminopropane;n-isopropylhydroxylamine n-hydroxypropan-2-amine 2-propanamine, n-hydroxy- 2-hydroxylaminopropane |
EN300-112062 |
n-isopropylhydroxylamine (15% solution in water) |
AT14836 |
Q27257766 |
SY277405 |
n-isopropylhydroxylamine, 15wt.% in h2o |
Z1198161074 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID191494 | Toxicity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain (4*10e6 dilution) | 1983 | Journal of medicinal chemistry, Mar, Volume: 26, Issue:3 | Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone. |
AID184705 | Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-98 strain | 1983 | Journal of medicinal chemistry, Mar, Volume: 26, Issue:3 | Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone. |
AID184702 | Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain | 1983 | Journal of medicinal chemistry, Mar, Volume: 26, Issue:3 | Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |